Active substance
Diphtheria, tetanus, pertussis, polio, hepatitis b
Where it is registered
Each register with its number of medicines and a few of them.
New Zealand
PHARMAC · 2 medicines
- Infanrix-hexaInj 30IU diphtheria with 40IU tetanus and 25mcg pertussis toxoids, 25mcg pertussis filamentous haemagglutinin, 8mcg pertactin, 80D-AgU polio virus, 10mcg hepatitis B antigen 10mcg H. influenzae type b with tetanus toxoid 20-40mcg in 0.5ml syringe
- Infanrix-hexaInj 30IU diphtheria with 40IU tetanus and 25mcg pertussis toxoids, 25mcg pertussis filamentous haemagglutinin, 8mcg pertactin, 80D-AgU polio virus, 10mcg hepatitis B antigen, 10mcg H. influenzae type b with tetanus toxoid 20-40mcg in 0.5ml syringe
All medicines with Diphtheria, tetanus, pertussis, polio, hepatitis b
Every register, a page at a time. Strengths and packs are on each medicine’s page.
19 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Infanrix-hexaCombination | New Zealand | Inj 30IU diphtheria with 40IU tetanus and 25mcg pertussis toxoids, 25mcg pertussis filamentous haemagglutinin, 8mcg pertactin, 80D-AgU polio virus, 10mcg hepatitis B antigen 10mcg H. influenzae type b with tetanus toxoid 20-40mcg in 0.5ml syringe | Funded | ||
| Infanrix-hexaCombination | New Zealand | Inj 30IU diphtheria with 40IU tetanus and 25mcg pertussis toxoids, 25mcg pertussis filamentous haemagglutinin, 8mcg pertactin, 80D-AgU polio virus, 10mcg hepatitis B antigen, 10mcg H. influenzae type b with tetanus toxoid 20-40mcg in 0.5ml syringe | Funded | ||
| PediarixCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| VaxelisCombination | United States | 0.5ML | Injection | Marketed | MSP Vaccine Company |
| VaxelisCombination | United States | 0.5ML | Injection | Marketed | MSP Vaccine Company |
| Hexyon | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Hexacima | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Infanrix Hexa | European Union | Authorised | GlaxoSmithKline Biologicals S.A. | ||
| Vaxelis | European Union | Authorised | MCM Vaccine B.V. | ||
| Infanrix HexaCombination | Canada | 25 LF / 0.5 ML + 25 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 8 MCG / 0.5 ML + 25 MCG / 0.5 ML + 40 UNIT / 0.5 ML + 8 UNIT / 0.5 ML + 32 UNIT / 0.5 ML + 10 LF / 0.5 ML + 40 MCG / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Hexaxim Suspension for Injection in Pre-Filled SyringeCombination | Singapore | 30 Lf (>= 20 IU)/0.5 mL + 25 μg/0.5 mL + 12 μg/0.5 mL + 10 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + 10 Lf (>= 40 IU)/0.5 mL | injection, suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Infanrix Hexa VaccineCombination | Singapore | min 30 iu/0.5 ml + 25 mcg/0.5 ml + 10 mcg/0.5 ml + 10 mcg/0.5 ml + 8 mcg/0.5 ml + 25 mcg/0.5 ml + 40 du/0.5 ml + 8 du/0.5 ml + 32 du/0.5 ml + min 40 iu/0.5 ml | injection | Authorised | Glaxosmithkline Pte LTD |
| Hexavac | European Union | Withdrawn | Sanofi Pasteur MSD, SNC | ||
| Infanrix Penta | European Union | Cancelled | GlaxoSmithKline Biologicals S.A. | ||
| Hexaxim VaccineCombination | Saudi Arabia | Authorised | Sanofi Pasteur SA | ||
| HEXAXIM vaccineCombination | Saudi Arabia | Authorised | Sanofi Pasteur | ||
| HEXAXIM vaccineCombination | Saudi Arabia | Authorised | Sanofi Pasteur | ||
| Infanrix Hexa VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Infanrix Hexa VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) |
At a glance
- Registers
- 1
- Medicines
- 2